Neurovations Research in Napa is proud to announce open enrollment for the RELIEV-CM2 study to evaluate the ShiraTronics Migraine Therapy System which is designed to provide relief, interruption, and prevention of migraine symptoms for chronic migraine sufferers
Neurovations Research, Dr. Melanie Johansson and Napa Pain Institute Take Triple Gold at Best of Napa 2024
By Jen Christensen, CNN The US Food and Drug Administration on Tuesday approved donanemab, a monoclonal antibody designed to slow the progression of early symptomatic Alzheimer’s disease. Donanemab, made by Indianapolis-based Eli Lilly, works by helping the body remove amyloid plaque buildup in the brain, a hallmark of Alzheimer’s disease.
Being Patient By Lauren Fetten | November 14th, 2023 Have you ever listened to someone with dementia counting or reciting numbers, or another familiar phrase, repeatedly? This isn’t an anomaly. Experts weigh in on what this behavioral symptom signifies and what to do when it happens.
Being Patient Alexandra Marvar As of a landmark policy change in October 2023, Medicare now covers PET scans to look for Alzheimer’s biomarker beta-amyloid in the brain for the general public. Up to this point, the Centers for Medicare & Medicaid Services (CMS) had refused to provide general Medicare coverage for Beta Amyloid Positron Emission Tomography scans (PET scans […]
In the illustrious history of the Lindalh Lectures at the Napa Pain Conference, we have been privileged to host some of the most brilliant minds in the scientific community. Among them, several luminaries have gone on to receive the highest honor in their respective fields – the Nobel Prize. Let’s celebrate their remarkable contributions: 1. Dr. […]
CEO and Founder of Neurovations Dr. Eric Grigsby Celebrates Three Decades of Innovation in Chronic Pain Management at 30th Napa Pain Conference NAPA, Calif., September 12, 2023 (Newswire.com) – The 30th Napa Pain Conference concluded on Aug. 20, 2023, celebrating three decades of unwavering commitment to advancing treatments and research for pain and neurological disease. The […]
MARTIN ESPINOZA THE PRESS DEMOCRAT Sonoma County neurologist Dr. Allan Bernstein envisions a day when Alzheimer’s disease can be treated as successfully as heart disease or even cancer. That day is far off, he said, but we’re getting closer. Bernstein, who has been involved in Alzheimer’s research for nearly 25 years, said part of the […]
Neurovations Research proud to be a part of study that released first positive results to slow Alzheimer’s Disease Napa, Calif., July 17, 2023 – Neurovations, a leading medical research and innovation company, is proud to have collaborated on a groundbreaking study investigating the effects of the monoclonal antibody, donanemab, on patients with the early stages […]
The Pain Institute welcomes newestpain intervention physician to the Napa Community June 1, 2023, Napa, Ca – Dr. Melanie Johansson joins the Napa Pain Institute as a fellowship-trained and board-certified pain management specialist with well over a decade of medical experience. Dr. Johansson treats patients for chronic back pain, headache and neuropathic pain, osteoporosis, chronic […]
Local Healthcare Entrepreneur Eric Grigsby, MD, MBA, is recognized for his efforts to keep Napa Community safe NapaCovid has been selected for the 2022 Best of Napa Award in the Medical Clinic category. Dr. Eric Grigsby, founder and CEO of Neurovations and Napa-based N3 Laboratories, supplied infrastructure for testing sites including a website, online and […]
Diabetic peripheral neuropathy is a debilitating, progressive neurologic disorder that affects about 30% of adults with diabetes. Spinal cord stimulation is a newer option for addressing moderate to severe pain related to the condition.